SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051427
Filing Date
2020-11-05
Accepted
2020-11-05 16:52:47
Documents
80
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pbyi-10q_20200930.htm   iXBRL 10-Q 2778348
2 EX-31.1 pbyi-ex311_12.htm EX-31.1 9311
3 EX-31.2 pbyi-ex312_10.htm EX-31.2 9310
4 EX-32.1 pbyi-ex321_11.htm EX-32.1 6276
5 EX-32.2 pbyi-ex322_8.htm EX-32.2 6292
  Complete submission text file 0001564590-20-051427.txt   10465503

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20200930.xsd EX-101.SCH 65438
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20200930_cal.xml EX-101.CAL 76023
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20200930_def.xml EX-101.DEF 204513
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20200930_lab.xml EX-101.LAB 552085
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20200930_pre.xml EX-101.PRE 407314
11 EXTRACTED XBRL INSTANCE DOCUMENT pbyi-10q_20200930_htm.xml XML 2067187
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 201291300
SIC: 2834 Pharmaceutical Preparations